IDT Biologika is an innovative, privately-held life science company which focuses on two core areas – contract manufacturing for biologics and its own animal health brand.
As a global leader in MVA technology, IDT Biologika develops new solutions for multiple innovative vaccines. The company offers development services and manufacturing facilities for clinical phase I to III as well as commercial supplies for leading-edge viral and bacterial human and animal health vaccines. IDT’s multipurpose production technology allows to manufacture different vaccine products on commercial scale, with the flexibility of manufacturing new products even at short notice.
Further specialized on developing and manufacture of sterile liquid drug products IDT is one of the few companies worldwide providing fully integrated industrialization services ranging from formulation process optimization and clinical manufacturing to large-scale production, packaging and quality control.
Also IDT has experience in technically sophisticated projects such as innovative biopharmaceuticals and lyophilized compounds manufactured in EMA and FDA-inspected facilities.
For more information about IDT Biologika, visit idt-biologika.com.